BIOLARGO, INC.
For the period ended Sep 30, 2025. Filed Nov 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 14, 2025
BLGOStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
BIOLARGO, INC.
FORM 10-Q
INDEX
Part I
| Item 1 | Financial Statements | 1 |
|---|---|---|
| Item 2 | Management's Discussion and Analysis and Financial Condition and Results of Operations | 27 |
| Item 4 | Controls and Procedures | 38 |
Part II
| Item 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 40 |
|---|---|---|
| Item 5 | Other Information | 40 |
| Item 6 | Exhibits | 41 |
| Signatures | 43 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.